Etiology: Lichen planus is a common, pruritic, inflammatory disease of the skin, hair follicles, and mucous membranes. The cause of lichen planus is unknown; however, some lichenoid rashes are ...

suggestions given during trance may help decrease skin pain and pruritus, intervene in psychosomatic aspects of skin diseases, and lead to the resolution of some skin diseases, including verruca ...

Targeting the kappa opioid receptor with an agonist is a new pharmacy strategy for treating moderate to severe CKD-associated ...

When people think about kidney disease, they often focus on its role in filtering blood, managing fluid levels, and balancing ...

On Friday, Eli Lilly and Company (NYSE:LLY) revealed new results from the Phase 3b ADapt study of Ebglyss (lebrikizumab), ...

Prior treatment use did not affect the efficacy or safety of topical ruxolitinib cream 1.5% for up to 52 weeks among patients with atopic dermatitis.

The following is a summary of “Assessing disease control in patients with atopic dermatitis by using the atopic dermatitis ...

One of the most common symptoms reported, as a result of the condition, is severe pruritus, with children ... can cause fibrosis and progressive liver disease. Approximately 95% of patients ...

TH104, the Company's lead candidate for moderate-to-severe pruritus in chronic liver disease, showed no opioid withdrawal effects, reinforcing ...

LIVMARLI, an IBAT inhibitor, is approved for the treatment of two rare liver diseases affecting children and adults. It is approved for the treatment of cholestatic pruritus in patients with ...

Kayfanda® (odevixibat) approved as new treatment choice for cholestatic pruritus in children from ... expands Ipsen’s rare cholestatic liver disease portfolio PARIS, FRANCE, xx September ...